October 18, 2021
The TGaS Summit will bring together life science professionals to hear the latest market trends, network, and share best practices. The Summit will feature 14 different categories of Commercial Client Solutions focused on key issues, challenges, and opportunities identified by Commercial Leaders. For more information on the TGaS Client Summits, please fill out the following and someone will contact you.…
April 1, 2021
Join Steve Yonish from Trinity and the Intellus Committee as they share results from the most recent Intellus Trends and Future survey. This study will provide insight into how the HC Insights & Analytics Community can address key challenges and the evolving needs of the Market Research Industry. Register Here: https://www.intellus.org/Events-Webinars/SummitVE-2021…
October 18, 2021
Join Trinity at AMCP NEXUS where we will share our integrated, evidence-based approach that helps clients make important decisions at the brand, business, and corporate levels including: corporate growth strategy: buy, build, or partner; business-unit and therapeutic-area assessments; identification of new business opportunities; resource allocation and investment decision support; In-depth market and competitive intelligence; development and optimization of new products; benchmarking and case studies; and strategic options/scenario analysis. #AMCPNexus Read more.…
March 9, 2021
Dmitry Kublanov VP, Contracting Trinity SPARC Trends in Contract Management Join Dmitry Kublanov from TGaS Advisors as he shares perspectives of Pricing & Contracting teams from various peer companies on the latest trends in contract management systems including realities of Value-Based contracting, operational budget pressures, challenges with contract profitability analysis, potential impact of the upcoming government legislations and other critical issues. Register Here: https://www.modeln.com/rainmaker/…
February 1, 2021
LSX World Congress Feb 1-5 https://www.lsxleaders.com/lsx-world-congress…
November 17, 2020
A Biopharma Industry Perspective on the Current and Future State of Incentive Compensation Join Trinity Life Sciences to hear highlights from our latest TGaS Landscape report entitled, “Tenth Annual Incentive Compensation Landscape.” This highly anticipated report is based on interviews of 38 biopharmaceutical incentive compensation (IC) leaders who shared their experiences on IC planning. The Tenth Annual edition is perhaps more critical than ever before as companies adapt IC approaches and plan amid COVID-19 challenges. From implementing COVID-specific Management by Objective…
November 5, 2020
Join Kevin Francis, Principal, Real-World Evidence, and Adrienne Lovink, Managing Director, Real-World Evidence in their discussion on breaking barriers to RWE use in commercialization planning and how Trinity EvidenceFirst™ is helping companies to take advantage of real-world insights like never before. Realizing the Value of RWE Data… Faster Biopharmaceutical companies recognize the value of RWE and strive to make it a routine part of their decision-making process. Many face challenges, however, with optimizing their use of RWE data in the…
October 28, 2020
You are invited to join us for a 30-minute webinar to see Trinity CloudCast™, the revolutionary connected forecasting platform for life sciences companies. A forecast is a business communications tool for an organization – a way to align the whole business around one common, quantitative language when speaking about the future. Trinity understands forecasting challenges. Built by pharma forecasters for pharma forecasters, CloudCast drives collaboration, clear visualization, and faster decision-making. During the webinar, we will demonstrate all the key features of CloudCast…
September 22, 2020
How has COVID-19 impacted launch performance and timing? Pharmaceutical leaders are facing some of the toughest challenges of their careers when it comes to launching in the midst of COVID-19. With so much at stake and so much uncertainty, companies are looking for fact-based insights to power their decision-making. Trinity has done an in-depth evaluation of the impact of COVID-19 on launch performance and timing. We have compared forecasted/expected revenue to actual revenue for products that launched within six months…
